Skip to main content
CYPH
NASDAQ Life Sciences

Cypherpunk Technologies Receives Nasdaq Delisting Deficiency Notice for Sub-$1.00 Bid Price

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.543
Mkt Cap
$30.745M
52W Low
$0.222
52W High
$3.7
Market data snapshot near publication time

summarizeSummary

Cypherpunk Technologies Inc. received a Nasdaq deficiency notice for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day period to regain compliance and avoid potential delisting.


check_boxKey Events

  • Nasdaq Deficiency Notice Received

    On March 4, 2026, Cypherpunk Technologies Inc. received a notification from Nasdaq for non-compliance with the minimum $1.00 closing bid price rule (Rule 5550(a)(2)).

  • Reason for Deficiency

    The company's common stock closing bid price has been below $1.00 per share for 30 consecutive business days.

  • Compliance Period

    The company has 180 calendar days, until August 31, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.

  • Potential Extension and Strategy

    An additional 180-day compliance period may be granted if other listing requirements are met. The company intends to monitor its stock price and consider options, including a reverse stock split, but offers no assurance of regaining compliance.


auto_awesomeAnalysis

Cypherpunk Technologies Inc. has received a formal notification from Nasdaq regarding its failure to maintain the minimum $1.00 bid price requirement. This deficiency notice is a critical event as it signals a potential threat to the company's continued listing on the Nasdaq Capital Market. While the company has 180 days to regain compliance, failure to do so could lead to delisting, significantly impacting liquidity and investor confidence. Investors should monitor the company's stock price performance and any strategic actions, such as a potential reverse stock split, that the company may undertake to cure the deficiency.

At the time of this filing, CYPH was trading at $0.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.7M. The 52-week trading range was $0.22 to $3.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CYPH - Latest Insights

CYPH
Apr 10, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
CYPH
Mar 16, 2026, 5:00 PM EDT
Filing Type: 10-K
Importance Score:
9
CYPH
Mar 16, 2026, 4:55 PM EDT
Filing Type: 8-K
Importance Score:
8
CYPH
Mar 09, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9